1. What Is the Immunoassay Market?
The Immunoassay Market covers laboratory-based antibody-antigen detection platforms for quantifying hormones, tumour markers, infectious disease antigens, therapeutic drug levels, and autoantibodies in clinical samples. Immunoassay encompasses chemiluminescent immunoassay, electrochemiluminescent immunoassay, enzyme-linked immunosorbent assay, fluorescent immunoassay, and multiplex immunoassay platforms. Market dynamics reflect high-throughput automated immunoassay adoption in core laboratories, multianalyte multiplex immunoassay demand, and point-of-care immunoassay expansion from the central lab.
2. Immunoassay Market Size & Forecast
3. Emerging Technologies
- Ultrasensitive immunoassay platforms enabling blood-based Alzheimer's diagnosis using p-tau and amyloid-beta biomarkers are advancing as transformational diagnostic tools. Growing adoption at neurology and dementia programmes is driven by CSF lumbar puncture avoidance requirements.
- Multiplex immunoassay panels simultaneously quantifying 20-plus analytes from a single sample are advancing as efficiency tools. Growing adoption at research and clinical labs is driven by sample volume and processing time reduction requirements.
- Automated immunoassay interfacing with laboratory information systems for sample routing and result validation are advancing. Growing adoption at high-throughput clinical labs is driven by laboratory workflow automation requirements.
- Direct digital immunoassay eliminating secondary antibody amplification steps are advancing as simplified detection tools. Growing adoption is driven by assay simplification and false positive rate reduction requirements.
Similar technologies are also transforming adjacent markets. Learn more in our Coagulation Poc Market.
4. Key Market Opportunity
Demand is strongest in the Immunoassay Market at the high-sensitivity cardiac troponin and brain natriuretic peptide opportunity, where ED rapid rule-out protocols drive high-volume testing. Alzheimer's blood biomarker immunoassay creates an emerging diagnostic opportunity as p-tau and amyloid-beta blood tests approach clinical standard of care. Therapeutic drug monitoring immunoassay creates a recurring revenue channel as biologic drug prescribing expands requiring level testing. Asia Pacific immunoassay creates geographic expansion as Chinese and Indian core laboratory infrastructure modernisation drives high-throughput immunoassay installation.
5. Top Companies in the Immunoassay Market
The following organisations hold leading positions in the Immunoassay Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Roche Diagnostics (Cobas e801)
- Abbott (Alinity i)
- Siemens Healthineers (Atellica)
- Beckman Coulter (DxI 9000)
- bioMerieux (VIDAS)
- Bio-Rad
- Luminex (DiaSorin)
- Quanterix (Simoa)
- Meso Scale Diagnostics
- Ortho Clinical Diagnostics
6. Market Segmentation
The Immunoassay Market is analysed across 3 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Technology | CLIA Chemiluminescent ECLIA ELISA FIA Fluorescent Multiplex |
| By Application | Hormones and Fertility Cardiac Biomarker Oncology Marker Infectious Disease Therapeutic Drug |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Immunoassay Market trajectory over the forecast period:
Roche Cobas e801 CLIA Analyser Achieves 70 Percent Global High-Throughput Immunoassay Market Share.Roche Diagnostics Cobas e801 electrochemiluminescent immunoassay system achieving 70 percent global high-throughput immunoassay market share by installed base in 2024 demonstrates ECLIA platform dominance. Roche Elecsys high-sensitivity troponin T achieving superior 99th percentile AMI rule-out performance versus competitors establishes cardiac biomarker ECLIA leadership.
Abbott Alinity i Achieves Rapid Core Lab Immunoassay Market Share Gains Through Performance and Throughput.Abbott Alinity i CLIA system achieving 25 percent new high-throughput immunoassay analyser placements in 2024 demonstrates competitive core lab market share gains over Roche Cobas installed base. Alinity i particle-enhanced turbidimetric immunoassay panel achieving 1,200 tests per hour demonstrates the throughput performance driving competitive placements.
Quanterix Simoa Single-Molecule Array Achieves Commercial Clinical Adoption for Ultrasensitive Biomarker Detection.Quanterix Simoa single-molecule array achieving 100-fold lower detection limits versus conventional ECLIA enabling neurofilament light and phospho-tau detection in blood in 2024 demonstrates ultrasensitive immunoassay entering clinical laboratory practice. Simoa NFL and p-tau217 blood tests achieving diagnostic performance approaching CSF biomarkers demonstrates liquid biopsy potential for Alzheimer's blood-based diagnosis.
For related market intelligence, see the Point Of Care Chemistry Market.
8. Segmental Analysis
By technology, the Chemiluminescent and ECLIA segment dominated the Immunoassay Market in 2025. Representing the largest revenue category as Roche Cobas e and Abbott Alinity i capture the high-throughput core lab market. The Ultrasensitive Single-Molecule Array segment is the fastest-growing category, advancing as Quanterix Simoa demonstrates blood-based Alzheimer's biomarker clinical validation.
By application, the Cardiac Biomarker segment dominated the Immunoassay Market in 2025. Representing the largest application revenue share. The Neurological Biomarker segment is the fastest-growing application category, advancing as clinical protocol standardisation and reimbursement expansion broaden market access. Both application dimensions indicate active transition between established Cardiac Biomarker demand and emerging Neurological Biomarker adoption.
9. Regional Analysis
Regional demand patterns across the Immunoassay Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Immunoassay Market in 2025, holding 39.1% of the global market. Clinical laboratories, hospital chemistry departments, and in vitro diagnostic manufacturers are deploying immunoassay systems for broad clinical analyte measurement including hormones, cardiac markers, infectious disease serology, and therapeutic drug monitoring. FDA IVD device clearance pathways and CMS laboratory reimbursement for immunoassay testing are encouraging clinical laboratories to invest in automated immunoassay analyser infrastructure. High clinical laboratory testing volumes, strong physician ordering of immunoassay panels, and large in vitro diagnostic manufacturer presence are generating strong regional immunoassay demand.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 9.14% during the forecast period. Clinical laboratories, hospital pathology departments, and point-of-care testing networks across China, India, Japan, and Southeast Asia are deploying automated immunoassay systems to serve growing clinical diagnostic workloads. Government investment in clinical laboratory infrastructure and increasing adoption of automated diagnostic platforms are creating demand for immunoassay systems capable of processing high sample volumes efficiently. Rising clinical testing volumes from expanding healthcare access, growing chronic disease burden, and increasing screening programme adoption are generating immunoassay demand.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Immunoassay Market was valued at USD 28.08 Bn in 2025 and is projected to reach USD 55.67 Bn by 2034, growing at a CAGR of 7.9% over the 2026–2034 forecast period.
The Immunoassay Market is projected to grow at a CAGR of 7.9% from 2026 to 2034.
North America accounted for the largest share of the Immunoassay Market in 2025, holding 39.1% of the global market.
The leading companies in the Immunoassay Market include Roche Diagnostics (Cobas e801), Abbott (Alinity i), Siemens Healthineers (Atellica), Beckman Coulter (DxI 9000), bioMerieux (VIDAS), Bio-Rad, Luminex (DiaSorin), Quanterix (Simoa), Meso Scale Diagnostics, Ortho Clinical Diagnostics.
Roche cobas e801 clia analyser achieves 70 percent global high-throughput immunoassay market share.
By technology, the Chemiluminescent and ECLIA segment dominated the Immunoassay Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.